Stockholders' Equity

6 Months Ended

Dec. 31, 2021

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

During the three months ended December 31, 2021 and 2020, the Company issued 0 shares and 0.2 million shares, respectively, of common stock upon the exercise of options. During the six months ended December 31, 2021 and 2020, the company issued 30,000 shares and 0.2 million shares, respectively, of common stock upon the exercise of options. During the three months ended December 31, 2021 and 2020, approximately 5,000 shares and 25,000 shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting. During the six months ended December 31, 2021 and 2020, approximately 24,000 shares and 0.1 million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.

On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million and, on August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 2023. During the three months ended December 31, 2021 and 2020, the Company purchased 0.5 million shares and 0.4 million shares, respectively, of common stock at an aggregate price of $3.2 million and $4.0 million under this repurchase program. During the six months ended December 31, 2021 and 2020, the Company purchased 0.9 million shares and 0.5 million shares, respectively, of common stock at an aggregate price of $6.6 million and $6.0 million under this repurchase program. At December 31, 2021, there is $4.9 million remaining under this repurchase program.

The Company’s Certificate of Incorporation authorizes the issuance of preferred stock. However, as of December 31, 2021, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company’s board of directors.